FDA sets PDUFA target action date of May 1, 2027NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a ...

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced topline results ...

Virtual Investor 'What This Means' segment highlights strategic Whitehawk collaboration, accelerating industry validation of ...

Microbiome sequencing services present opportunities in precision health, pharma, food safety, agriculture, AI integration, ...

Discover how Orange County AI startups are scaling AI-native companies to automate workflows in healthcare, finance, and ...

(NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for Priority Review a supplemental New Drug Application (sNDA) for TALZENNA ® (talazoparib), an oral poly ...

The Global Carrot Seed Oil Market is experiencing sustained expansion as manufacturers, formulators, and wellness-focused ...

SEM supports modern plant taxonomy through detailed imaging of trichomes, stomata, and other species-specific surface ...

Top Talk Summit was held in June during MWC Shanghai 2026. The event gathered 150 industry experts, including mobile telecom ...

AI infrastructure demands full-stack integration over portability, forcing CIOs to view vendor lock-in as a strategic choice rather than a procurement failure.

State-level AI laws are being enacted at a rapid pace, but this is creating a Byzantine array of AI restrictions. AI makers ...

FDA sets PDUFA target action date of May 1, 2027 NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of ...